Ceftriaxone, powder for injection 1 g, Noradrenaline, concentrate for solution for infusion, 2 mg/ml in 8 ml, Oxytocin, solution for injection 5 IU/ml (CPV: 33600000-6 Pharmaceutical products)

This tender, issued by the Communal Non-Profit Enterprise "Illinetska City Hospital" of the Illinetska City Council, concerns the procurement of essential pharmaceutical products. The specific items required are Ceftriaxone, a powder for injection in 1 g vials, categorized under General anti-infectives for systemic use, vaccines, antineoplastics and immunomodulators (CPV: 33650000-1). Additionally, the tender includes Noradrenaline, a concentrate for solution for infusion, presented as 2 mg/ml in 8 ml vials, falling under Medicines for blood and blood-forming organs and cardiovascular system diseases (CPV: 33620000-2). The third item is Oxytocin, a solution for injection at 5 IU/ml, classified under Medicines for genito-urinary system and hormones (CPV: 33640000-8). A critical condition for this procurement is that the supplied goods must not originate from the Russian Federation, the Republic of Belarus, and/or the Islamic Republic of Iran. This procurement aims to ensure the availability of vital medications for the hospital's operations, adhering to strict origin restrictions for the supplied pharmaceuticals.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 25,847.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.